TABLE 1

Performance of commercial urinary lipoarabinomannan (LAM) tests

Sensitivity %Specificity %
TB-LAM (Clearview) ELISA [56]
 HIV-positive patients51 (32–69)94 (79–98)
 HIV-negative patients14 (7–24)97 (90–99)
Determine (Alere) TB-LAM test [57]
 HIV-positive patients45 (29–63)92 (80–97)
 HIV-negative patientsNDND

Data are presented as median (range). TB: tuberculosis; ND: not determined.